News (192)

Guardant Health Named to TIME100 Most Influential Companies BU
Guardant Health to Present Studies at 2024 ASCO Annual Meeting Highlighting Contributions of Its Blood Tests and Real-World Data to Advancing Precision Oncology and Cancer Screening BU
Guardant Health Receives EU IVDR Certification for Guardant360® CDx Liquid Biopsy for Tumor Mutation Profiling Across All Solid Cancers and Companion Diagnostic Indications BU
Transcript : Guardant Health, Inc., Q1 2024 Earnings Call, May 09, 2024
Guardant Health Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance BU
Guardant Health Surpasses 500 Peer-Reviewed Publications Milestone BU
Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting BU
Transcript : Guardant Health, Inc., Q4 2023 Earnings Call, Feb 22, 2024
Guardant Health Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook BU
Transcript : Guardant Health, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-08-2024 03:45 PM
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2023 Results BU
Guardant Health Appoints Terilyn Juarez Monroe as Chief People Officer BU
Guardant Health Announces $90.7 Million Registered Direct Offering with Baillie Gifford BU
Cancer Research UK and Guardant Health Launch Collaboration to Advance Cancer Research and Clinical Development Activities BU
Guardant Health to Appeal Federal District Court Verdict BU
Transcript : Guardant Health, Inc., Q3 2023 Earnings Call, Nov 06, 2023
Guardant Health Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance BU
Transcript : Guardant Health, Inc. Presents at Morgan Stanley 21st Annual Global Healthcare Conference 2023, Sep-11-2023 11:20 AM
Transcript : Guardant Health, Inc. - Analyst/Investor Day
Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan BU
Guardant Health Receives Regulatory Approval in Japan for Guardant360® CDx as Companion Diagnostic to ENHERTU® for Treatment of Non-Small Cell Lung Cancer Patients with HER2 Mutations BU
Transcript : Guardant Health, Inc., Q2 2023 Earnings Call, Aug 03, 2023
Guardant Health Reports Second Quarter 2023 Financial Results and Increases Revenue Guidance BU
Guardant Health receives first commercial payor coverage for Guardant Reveal™ test from Blue Cross and Blue Shield of Louisiana BU
Guardant Health announces reimbursement approval of Guardant360® CDx liquid biopsy test in Japan BU
Transcript : Guardant Health, Inc. Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-12-2023 04:00 PM
Transcript : Guardant Health, Inc. Presents at The 43rd Annual William Blair Growth Stock Conference, Jun-06-2023 04:40 PM
Guardant Health to present 17 scientific abstracts highlighting contribution of its blood tests and real-world data to advances in precision oncology and cancer screening at 2023 ASCO annual meeting BU
Guardant Health Secures Coverage From Major US Commercial Health Insurers for Guardant360® Blood Test for Comprehensive Genomic Profiling BU
Guardant Health Releases Inaugural ESG Report BU
Transcript : Guardant Health, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-10-2023 02:20 PM
Transcript : Guardant Health, Inc., Q1 2023 Earnings Call, May 09, 2023
Guardant Health Reports First Quarter 2023 Financial Results BU
Guardant Health Announces Additions to Leadership Team BU
Guardant Health and Parker Institute for Cancer Immunotherapy (PICI) launch research collaboration to study connection between cancer biomarkers and immunotherapy treatment response BU
Guardant Health Receives Medicare Coverage for Guardant360 Response™ to Monitor Cancer Patient Response to Immunotherapy BU
Guardant Health to Present Data From 14 Studies Highlighting Advances in Precision Oncology and Cancer Screening at 2023 AACR Annual Meeting BU
Transcript : Guardant Health, Inc. Presents at Cowen 43rd Annual Healthcare Conference, Mar-08-2023 10:30 AM
Musa Tariq Joins Guardant Health Board of Directors BU
Transcript : Guardant Health, Inc., Q4 2022 Earnings Call, Feb 23, 2023
Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook BU
Guardant Health receives coverage from UnitedHealthcare for Guardant360® CDx blood test as companion diagnostic in advanced lung and breast cancer BU
Guardant Health and AnHeart Therapeutics Announce Collaboration to Develop Guardant360® CDx and Guardant360 TissueNext™ as Companion Diagnostics for Taletrectinib in Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer BU
Guardant Health introduces Guardant GalaxyTM suite of advanced AI analytics to enhance its portfolio of cancer tests and accelerate biomarker discovery BU
Guardant Health receives FDA approval for Guardant360® CDx as companion diagnostic for Menarini Group’s ORSERDU™ for treatment of patients with ESR1 mutations in ER+, HER2- advanced or metastatic breast cancer BU
1234NextSee all

Insiders

Picture Helmy Eltoukhy
Helmy Eltoukhy

Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. He previously occupied the position of Director-Advanced Technology Research at Illumina, Inc. and President & Chief Executive Officer of Avantome, Inc. (a subsidiary of Illumina, Inc.) and Principal at Stanford Genome Technology Center. Dr. Eltoukhy received an undergraduate degree, a doctorate and a graduate degree from Stanford University.


Picture Mohamad Helmy bin Othman Basha
Mohamad Helmy bin Othman Basha

Mr. Mohamad Helmy bin Othman Basha is a Group Managing Director & Director at Sime Darby Plantation Bhd., a President at Malaysia Agricultural Producers Association, a Managing Director & Director at CHEMARA Palmea Holdings Bhd., a Member at Malaysian Institute of Accountants and a Member at The Incorporated Society of Planters. He is on the Board of Directors at Sime Darby Plantation Bhd. and CHEMARA Palmea Holdings Bhd. Mr. bin Othman Basha was previously employed as a Chief Executive Officer by Guthrie Ropel Bhd., a Chief Executive Officer by Highlands & Lowlands Bhd., a Manager-Finance & Administration by Guthrie Property Development Holdings Bhd., a Head-Corporate Planning & Strategic Development by Kumpulan Guthrie Bhd., a Member by Acca Malaysia Sdn. Bhd., an Area Accountant by Shell Malaysia Trading Sdn. Bhd., a Head-Accounts by Hengyuan Refining Co. Bhd., and an Auditor by The Oxford.


Picture Eddie Eltoukhy
Eddie Eltoukhy

Eddie Eltoukhy is currently a Partner at Pear Ventures Management LLC.
He holds an MBA from Stanford University.


Picture Adam Eltoukhy
Adam Eltoukhy

Adam Eltoukhy is currently the Director at Samsara Networks Ltd.
and also holds the position of Secretary, Chief Legal Officer & Executive VP at Samsara, Inc. Previously, he worked as a Legal Counsel at Palantir Technologies, Inc. from 2012 to 2018.
He also has experience as an Associate at Morrison & Foerster LLP and Weil, Gotshal & Manges LLP.
Mr. Eltoukhy completed his undergraduate degree at Santa Clara University and his graduate degree at Stanford Law School.


Picture Shafy Eltoukhy
Shafy Eltoukhy

Shafy Eltoukhy is currently the Chief Executive Officer at Open-Silicon, Inc. and the Senior Vice President & General Manager at SiFive, Inc. Previously, he held positions such as Director-Technology Development at Microsemi SoC Corp., Principal at Intel Corp., Vice President-Operations & Technology Development at Open-Silicon, Inc., Faculty Member at The University of Waterloo, Vice President-Technology at Lightspeed Logic, Inc., and Faculty Member at the University of Cairo.
He holds a doctorate degree from The University of Waterloo and undergraduate and graduate degrees from the University of Cairo.





Picture Yashar Hassan Abbas Helmy
Yashar Hassan Abbas Helmy

Yashar Hassan Abbas Helmy has a current job as the Chairman at Pharco Pharmaceuticals, Inc.



Picture Hany Helmy
Hany Helmy

Hany Helmy is currently working as a Location Manager at Al-Sawani Group.


Picture Helmy Said
Helmy Said

Helmy Said worked as a Director of Human Resources & General Affairs at PT Elnusa Tbk and as a Manager of System, Method & Productivity at PT Pertamina (Persero).
He graduated from the University of Indonesia in 1998 and received his undergraduate degree from Sriwijaya University in 1984.


Picture Isfhan Helmy
Isfhan Helmy

Isfhan Helmy currently works as the Head of Research at PT Sinarmas Sekuritas.





Picture Karim Helmy
Karim Helmy

Karim Helmy is a Managing Director focused on the Healthcare sector for the private equity team.
Prior to joining Viking in 2020, Karim was a Vice President at Venrock, where he focused on venture-stage healthcare investments, and an Engagement Manager at McKinsey & Company, where he was a leader in the Pharmaceuticals Research & Development Practice.
Karim received a joint M.D./Ph.D.
from New Jersey Medical School and completed an internship in Internal Medicine at Columbia University Medical Center.
Before medical school, he worked in discovery research at Genentech.
Karim received a B.S.
in biology from Stanford University.




Picture Fuad Helmy
Fuad Helmy

Fuad Helmy is currently the Director at PT Dairi Prima Mineral and the Chief Financial Officer at PT Bumi Resources Minerals Tbk.
He previously worked as the Vice President-Business Analyst Division at PT Bumi Resources Tbk.
He completed his undergraduate degree from Universitas Trisakti.





Picture Helmy Munieb Helmy Armoush
Helmy Munieb Helmy Armoush

Helmy Munieb Helmy Armoush worked as a General Manager at Jordan National Shipping Lines and Gulf Navigation Holding PJSC.




Picture Mahmoud Helmy
Mahmoud Helmy

Mahmoud Helmy has a current job as the Head of Technical Affairs at Eastern Co. (Egypt).






Picture Hassan Ahmed Mohamed Helmy
Hassan Ahmed Mohamed Helmy

Hassan Ahmed Mohamed Helmy is a member of The Egyptian Society of Accountants & Auditors.
He was previously the CFO & Senior Vice President-Administrative Affairs at Telecom Egypt from 2013 to 2016.
He obtained an undergraduate degree from the University of Cairo.



Picture Taher S. Helmy
Taher S. Helmy

Taher S.
Helmy
is the founder who established Helmy, Hamza & Partners in 1986.
He also worked as a Director at AMIDEAST, Inc.



Picture Hany Helmy
Hany Helmy

Hany Helmy worked as an Actuarial Manager at Al Fajer Retakaful Insurance Co. KSCC.



Picture Hanaa Helmy
Hanaa Helmy

Hanaa Helmy is associated with the EFG Hermes Foundation as the Chief Executive Officer since 2006.



Picture Alaa Mohammad Helmy
Alaa Mohammad Helmy

Alaa Mohammad Helmy currently works at Ismailia National Food Industries, as Non-Executive Director.






Picture Ahmed Yousri Helmy
Ahmed Yousri Helmy

Ahmed Yousri Helmy currently works as a Group Chief Financial Officer at National Real Estate Co.


Picture Hend Helmy
Hend Helmy

Hend has 5 years of work experience specialized in Business Development in diversified market sectors.
Hend has been with Nile Capital and IT Ventures since November 2008.
Prior to joining Nile Capital, she has worked in a key government agency serving Egypt’s industrial sectors and promoting development, and she also worked in an industrial company focusing on product and operational development.
Hend graduated from the John Molson School of Business with a major in Marketing at Concordia University with Honors in 2005 and earned her Master of Business Administration degree, specialized in Operations Management from the American University in Cairo in 2008.
She also achieved an Advanced Corporate Finance and Investment Specialist Diploma from the American University in Cairo in 2009.
Major areas of expertise are operational effectiveness, marketing communications, and opportunity analysis.










Picture Shereen Hassan Abbas Helmy
Shereen Hassan Abbas Helmy

Shereen Hassan Abbas Helmy is currently the Chief Executive Officer at Pharco Pharmaceuticals, Inc. He is also currently serving as the Director at Alexandria University, the National Authority For Quality Assurance & Accreditation In Ed, the Egypt-Japan University of Science & Technology, and the Egyptian Accreditation Council.
Additionally, he is a Member of the Egyptian Export Council of Medical Industries.
Shereen's former position was as a Non-Executive Director at Beltone Financial Holding.
He holds an MBA from Central Michigan University, an undergraduate degree from Alexandria University, an MBA from Arab Academy for Science, Technology & Maritime Transport, and a doctorate degree from Arab Academy for Science, Technology & Maritime Transport.





Picture Amr Helmy
Amr Helmy

Amr Ahmed Helmy currently works at Rowad Misr Tourism Investment, as Independent Non-Executive Director and Sharm Dreams Co. for Tourism Investment, as Chief Financial & Investor Relations Officer.


Picture Hassan Helmy
Hassan Helmy

Mr. Hassan Helmy is on the Board of Directors at Lingo Media Corp.
Mr. Helmy was previously employed as Group Chief Financial Officer by Global Telecom Holding SAE.


Picture Helmy Taha Mohammed Omran
Helmy Taha Mohammed Omran

Helmy Taha Mohammed Omran was the Chairman of Ismailia National Food Industries.
He obtained an undergraduate degree from Ain Shams University in 1970 and a graduate degree from the same university in 1974.








Picture Mohamad Helmy Ibrahim
Mohamad Helmy Ibrahim

Mohamad Helmy Ibrahim is the founder of Rangkai Positif Sdn.
Bhd.
He currently works as the Head of International & Investment Management at Malakoff Corp.
Bhd.
He previously worked as the General Manager at Jimah Energy Ventures Sdn.
He received his undergraduate degree from the University of Leeds.


Picture Helmy Yusman Santoso
Helmy Yusman Santoso

Helmy Yusman Santoso is currently the Chief Financial Officer, Secretary & Director at PT Tower Bersama Infrastructure Tbk since 2010.
He is also a Director at PT Metric Solusi Integrasi and PT Solusi Menara Indonesia.
In 2019, he became the President Commissioner at PT Visi Telekomunikasi Infrastruktur Tbk.
Previously, Mr. Santoso served as the President Director at PT Astra Auto Finance from 2007 to 2008.
He was also a Director at PT Solu Sindo Kreasi Pratama.
Prior to that, he held the position of Head-Treasury & Finance Division at PT Astra Sedaya Finance from 2002 to 2007.
Mr. Santoso completed his undergraduate degree from Universitas Trisakti in 1998.



Picture Helmy Faishal Zaini
Helmy Faishal Zaini

Helmy Faishal Zaini served as the Minister for Development of Disadvantaged Regions in the Government of Indonesia.





Picture Syed Ahmad Helmy bin Syed Ahmad
Syed Ahmad Helmy bin Syed Ahmad

Syed Ahmad Helmy bin Syed Ahmad is the founder of S.
A Helmy & Partners established in 1985.
He is currently the Chairman of Advocates & Solicitors Disciplinary Board since 2012.
Mr. bin Syed Ahmad's former positions include being an Independent Non-Executive Director at AEON Co. (Malaysia) Bhd.
from 2013 to 2023 and a Director at Export-Import Bank of Malaysia Bhd.
His education history includes graduating from the National University of Singapore in 1971.

No results for this search

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW